Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Deloitte
AstraZeneca
Julphar
Argus Health
Citi
UBS
Johnson and Johnson
Accenture
Harvard Business School

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021993

« Back to Dashboard
NDA 021993 describes CLARITIN REDITABS, which is a drug marketed by Bayer Healthcare Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the CLARITIN REDITABS profile page.

The generic ingredient in CLARITIN REDITABS is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the loratadine profile page.

Summary for NDA: 021993

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021993

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITIN REDITABS
loratadine
TABLET, ORALLY DISINTEGRATING;ORAL 021993 NDA Bayer HealthCare LLC 11523-7202 11523-7202-1 3 BLISTER PACK in 1 CARTON (11523-7202-1) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
CLARITIN REDITABS
loratadine
TABLET, ORALLY DISINTEGRATING;ORAL 021993 NDA Bayer HealthCare LLC 11523-7202 11523-7202-3 1 BLISTER PACK in 1 CARTON (11523-7202-3) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, ORALLY DISINTEGRATING;ORALStrength5MG
Approval Date:Dec 12, 2006TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Mallinckrodt
US Department of Justice
Federal Trade Commission
US Army
Fish and Richardson
Dow
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot